NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NPO Petrovax Pharm LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11162
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides cosmetic and veterinary products. Petrovax offers products in the therapeutic areas of infection diseases, immunology, urology, gynecology, and reproductive health. The company works in partnership with pharmaceutical companies and research and development institutions to develop new products. It commercializes its products in Ukraine, Belarus, Kazakhstan, Kyrgyzstan, Azerbaijan, Uzbekistan, Georgia, Moldova and Slovakia among others. Petrovax is headquartered in Moscow, Russia.

NPO Petrovax Pharm LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Petrovax Pharm Enters into Cooperation Agreement with Scientific Research Institute of Vaccines 10
Acquisition 11
Interros Acquires Controlling Stake in NPO Petrovax Pharm, Vaccine Maker 11
Russian Authorities Reject Abbott’s Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 12
NPO Petrovax Pharm LLC – Key Competitors 14
NPO Petrovax Pharm LLC – Key Employees 15
NPO Petrovax Pharm LLC – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Legal and Regulatory 17
Oct 18, 2017: Petrovax Pharm successfully certified for ISO 9001:2015 conformity 17
Mar 09, 2017: NPO Petrovax Pharm recertified for Russian GMP conformance of pharmaceutical manufacture and Quality Management System 18
Product News 19
Oct 10, 2017: Innovative thrombolytics for acute myocardial infarction readily accessible for Russian patients 19
May 16, 2017: Commercial batches of localized innovative thrombolytics to be launched to Russian market in June 20
Mar 13, 2017: NPO Petrovax Pharm launched PHARDO system for trial period 22
Other Significant Developments 23
May 06, 2017: Navicon updated CRM system at Petrovax Pharm 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Key Facts 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NPO Petrovax Pharm LLC, Deals By Therapy Area, 2012 to YTD 2018 8
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Petrovax Pharm Enters into Cooperation Agreement with Scientific Research Institute of Vaccines 10
Interros Acquires Controlling Stake in NPO Petrovax Pharm, Vaccine Maker 11
Russian Authorities Reject Abbott's Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 12
NPO Petrovax Pharm LLC, Key Competitors 14
NPO Petrovax Pharm LLC, Key Employees 15
NPO Petrovax Pharm LLC, Other Locations 16

List of Figures
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Burke-Divide Electric Cooperative Inc:企業の戦略的SWOT分析
    Burke-Divide Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Queen Mary University of London-製薬・医療分野:企業M&A・提携分析
    Summary Queen Mary University of London (Queen Mary), formerly Queen Mary and Westfield College, a subsidiary of University of London, is a research university that offers undergraduate and postgraduate education; and research programs. The university provides graduation and education services in ar …
  • Eiffage SA (FGR):電力:M&Aディール及び事業提携情報
    Summary Eiffage SA (Eiffage) is a construction and concession company. It operates in businesses of energy and infrastructure construction, real estate development, road construction, civil engineering, concessions, and public-private partnerships. The company’s activities include construction, reno …
  • Great Wolf Resorts Inc:戦略・SWOT・企業財務分析
    Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Great Wolf Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • American Air Filter Co Inc:企業の戦略的SWOT分析
    American Air Filter Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ATI Physical Therapy-製薬・医療分野:企業M&A・提携分析
    Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy services. The center offers therapy services such as physical therapy, workers' comp rehab, sports therapy, hand therapy, women's health, specialty therapies, home health and complimentary injury screening servic …
  • Toda Corporation:企業の戦略・SWOT・財務分析
    Toda Corporation - Strategy, SWOT and Corporate Finance Report Summary Toda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Chiesi Farmaceutici SpA:企業の戦略的SWOT分析
    Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Delphi Energy Corp (DEE):石油・ガス:M&Aディール及び事業提携情報
    Summary Delphi Energy Corp (Delphi Energy) is an independent oil and natural gas producing company. The company acquires and explores for, develops and produces crude oil and natural gas. It also carries out the production of natural gas liquids. Delphi Energy’s operations are primarily concentrated …
  • The Islamic Insurance Company:企業の戦略・SWOT・財務情報
    The Islamic Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Islamic Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • General Re Corporation:企業の戦略・SWOT・財務分析
    General Re Corporation - Strategy, SWOT and Corporate Finance Report Summary General Re Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nihon Kohden Corp (6849)-医療機器分野:企業M&A・提携分析
    Summary Nihon Kohden Corp (Nihon Kohden) is a provider of medical electronic equipment to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyo …
  • Rinnai Corp (5947):企業の財務・戦略的SWOT分析
    Rinnai Corp (5947) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Duke Energy Indiana LLC:企業の戦略的SWOT分析
    Duke Energy Indiana LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Grupo Bimbo, S.A.B. de C.V. (BIMBOA):企業の財務・戦略的SWOT分析
    Grupo Bimbo, S.A.B. de C.V. (BIMBOA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Methanol Chemicals Co (2001):企業の財務・戦略的SWOT分析
    Methanol Chemicals Co (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding royalty i …
  • Ingersoll-Rand Plc (IR):電力:M&Aディール及び事業提携情報
    Summary Ingersoll-Rand Plc (Ingersoll-Rand) is an industrial manufacturer. It designs, manufactures, sells and services a portfolio of industrial and commercial products. The company’s offerings enhance the quality, energy efficiency and comfort of air in homes and buildings, transport and protect f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆